ASPN ASPEN AEROGELS INC

NYSE aerogel.com


$ 8.90 $ 0.00 (0 %)    

Thursday, 16-Oct-2025 05:18:26 EDT
QQQ $ 605.09 $ 0.00 (0 %)
DIA $ 464.36 $ 0.00 (0 %)
SPY $ 667.35 $ 0.00 (0 %)
TLT $ 90.93 $ 0.00 (0 %)
GLD $ 389.42 $ 0.00 (0 %)
$ 8.82
$ 8.48
$ 8.90 x 305
$ 8.94 x 20
-- - --
$ 4.16 - $ 26.90
2,525,111
na
726.42M
$ 1.88
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-27-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 03-07-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 03-16-2023 12-31-2022 10-K
12 11-07-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-04-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 03-12-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-05-2020 06-30-2020 10-Q
22 05-04-2020 03-31-2020 10-Q
23 03-06-2020 12-31-2019 10-K
24 11-01-2019 09-30-2019 10-Q
25 08-02-2019 06-30-2019 10-Q
26 05-03-2019 03-31-2019 10-Q
27 03-08-2019 12-31-2018 10-K
28 11-07-2018 09-30-2018 10-Q
29 08-03-2018 06-30-2018 10-Q
30 05-04-2018 03-31-2018 10-Q
31 03-01-2018 12-31-2017 10-K
32 11-03-2017 09-30-2017 10-Q
33 08-04-2017 06-30-2017 10-Q
34 05-05-2017 03-31-2017 10-Q
35 03-02-2017 12-31-2016 10-K
36 11-03-2016 09-30-2016 10-Q
37 08-05-2016 06-30-2016 10-Q
38 05-06-2016 03-31-2016 10-Q
39 03-04-2016 12-31-2015 10-K
40 11-06-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-downgrades-aspen-aerogels-to-underweight-lowers-price-target-to-6

Barclays analyst David Anderson downgrades Aspen Aerogels (NYSE:ASPN) from Equal-Weight to Underweight and lowers the price ...

 canaccord-genuity-maintains-buy-on-aspen-aerogels-lowers-price-target-to-10

Canaccord Genuity analyst George Gianarikas maintains Aspen Aerogels (NYSE:ASPN) with a Buy and lowers the price target from...

 aspen-aerogels-sees-fy2025-gaap-eps-386-373-vs-282-est-sees-sales-297m-317m-vs-296517m-est

Second Half of 2025 Financial OutlookAspen's second half of 2025 Outlook is as follows:($ in millions, except per share amo...

 aspen-aerogels-q2-adj-eps-004-beats-009-estimate-sales-7802m-beat-7253m-estimate

Aspen Aerogels (NYSE:ASPN) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.09) ...

 barclays-downgrades-aspen-aerogels-to-equal-weight-lowers-price-target-to-7

Barclays analyst David Anderson downgrades Aspen Aerogels (NYSE:ASPN) from Overweight to Equal-Weight and lowers the price t...

 aspen-aerogels-sees-q2-gaap-eps-013-005-vs-001-est-sees-sales-70m-80m-vs-9083m-est

Aspen Aerogels (NYSE:ASPN) is looking for Q2 GAAP EPS of $(0.13)-$(0.05) vs $0.01 analyst estimate. sees sales of $70.000 milli...

 aspen-aerogels-q1-adj-eps-006-beats-007-estimate-sales-7872m-miss-8275m-estimate

Aspen Aerogels (NYSE:ASPN) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) ...

 b-riley-securities-maintains-buy-on-aspen-aerogels-lowers-price-target-to-22

B. Riley Securities analyst Ryan Pfingst maintains Aspen Aerogels (NYSE:ASPN) with a Buy and lowers the price target from $3...

 barclays-maintains-overweight-on-aspen-aerogels-lowers-price-target-to-13

Barclays analyst David Anderson maintains Aspen Aerogels (NYSE:ASPN) with a Overweight and lowers the price target from $25 ...

 roth-mkm-maintains-buy-on-aspen-aerogels-lowers-price-target-to-16

Roth MKM analyst Chip Moore maintains Aspen Aerogels (NYSE:ASPN) with a Buy and lowers the price target from $22 to $16.

 canaccord-genuity-maintains-buy-on-aspen-aerogels-lowers-price-target-to-15

Canaccord Genuity analyst George Gianarikas maintains Aspen Aerogels (NYSE:ASPN) with a Buy and lowers the price target from...

 craig-hallum-maintains-buy-on-aspen-aerogels-lowers-price-target-to-18

Craig-Hallum analyst Eric Stine maintains Aspen Aerogels (NYSE:ASPN) with a Buy and lowers the price target from $21 to $18.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION